AZN
Shareholders that lost money on AstraZeneca PLC (AZN) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
NEW YORK, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in AstraZeneca PLC ("AstraZeneca" or the...
Read moreDetails
Class Action Filed Against AstraZeneca PLC (AZN) – February 21, 2025 Deadline to Join – Contact The Gross Law Firm
NEW YORK , Dec. 30, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of AstraZeneca...
Read moreDetails
ASTRAZENECA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against AstraZeneca PLC – AZN
NEW ORLEANS , Dec. 27, 2024 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of...
Read moreDetails
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines – AZN
NEW YORK , Dec. 27, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC...
Read moreDetails
AstraZeneca (AZN) Reels from China Investigation and Investor Suit – Hagens Berman
SAN FRANCISCO, Dec. 27, 2024 (GLOBE NEWSWIRE) -- AstraZeneca, the Anglo-Swedish pharmaceutical giant, has seen its stock price tumble 15...
Read moreDetails
Here’s Why Astrazeneca (AZN) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top...
Read moreDetails
AZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK , Dec. 26, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm,...
Read moreDetails
AstraZeneca (AZN) Faces Securities Class Action After Reports of PRC Probe into Fraud and Corruption – Hagens Berman
SAN FRANCISCO, Dec. 26, 2024 (GLOBE NEWSWIRE) -- AstraZeneca, the British-Swedish pharmaceutical giant, is facing a securities class action lawsuit...
Read moreDetails
AZN, Daiichi Withdraw EU Filing for Dato-DXd in Nonsquamous NSCLC
AstraZeneca and Daiichi Sankyo voluntarily withdraw regulatory filing for Dato-DXd in nonsquamous non-small cell lung cancer in the European Union.
Read moreDetails
AZN INVESTOR DEADLINE: AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO , Dec. 26, 2024 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that...
Read moreDetails